Wang et al. (2022) found that higher levels of apolipoproteins and triglycerides in the blood of prostate cancer patients correlate with increased expression of enzymes involved in lipid metabolism, such as FASN and ACC1, which are known to activate NF-κB signaling [9]. Here, FASN is linked to prostate cancer.